@EricTopol
Compared to insulin, GLP-1RAs (glucagon-like peptide 1 receptor agonists) were associated with a significantly lower risk of 10 out of the 13 obesity-associated cancers, including gallbladder cancer, meningioma, pancreatic cancer, liver cancer, ovarian cancer, colorectal cancer,